Kalbitor and Klor-con drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Kalbitor (ecallantide) and Klor-con (potassium chloride). Common drug interactions include depressed mood among females and liposarcoma among males.

The phase IV clinical study analyzes what interactions people have when they take Kalbitor and Klor-con. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Kalbitor?

Kalbitor has active ingredients of ecallantide. eHealthMe is studying from 2,079 Kalbitor users. Check the latest studies of Kalbitor.

What is Klor-con?

Klor-con has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 27,547 Klor-con users. Check the latest studies of Klor-con.



On Jul, 17, 2026

18 people who take Kalbitor and Klor-con together, and have interactions are studied.

Kalbitor and Klor-con drug interactions.

What are the common drug interactions of Kalbitor and Klor-Con, by gender? *:

female:

  1. Depressed mood
  2. Device related infection
  3. Drug ineffective
  4. Erythema (redness of the skin)
  5. Feeling hot
  6. Infection
  7. Malaise (a feeling of general discomfort or uneasiness)
  8. Muscle spasms (muscle contraction)
  9. Pain in extremity
  10. Pigmentation disorder (disturbances of human skin colour)

male:

  1. Liposarcoma (a cancer tumour that arises in fat cells in deep soft tissue)
  2. Post procedural infection

What are the common drug interactions of Kalbitor and Klor-Con, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Hereditary angioedema (recurrent episodes of severe swelling)
  2. Cardiac infection (an infection of the heart)
  3. Infusion site infection
  4. Cardiac valve vegetation (heart valve abnormal growth)
  5. Catheter site infection (infection at the site of insertion)
  6. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  7. Depressed mood
  8. Device related infection
  9. Infection
  10. Malaise (a feeling of general discomfort or uneasiness)

40-49:

  1. Liposarcoma (a cancer tumour that arises in fat cells in deep soft tissue)
  2. Post procedural infection

50-59:

n/a

60+:

  1. Hereditary angioedema (recurrent episodes of severe swelling)
  2. Blood potassium decreased
  3. Cough
  4. Road traffic accident
  5. Cellulitis (infection under the skin)
  6. Drug ineffective
  7. Erythema (redness of the skin)
  8. Feeling hot
  9. Muscle spasms (muscle contraction)
  10. Pain in extremity

What are the existing conditions these people have? *

  1. Hereditary Angioedema (recurrent episodes of severe swelling): 18 people, 100.00%
  2. Transient Ischaemic Attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow)): 2 people, 11.11%
  3. Muscle Spasms (muscle contraction): 2 people, 11.11%
  4. Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 2 people, 11.11%
  5. High Blood Pressure: 2 people, 11.11%
  6. Laxative Supportive Care: 2 people, 11.11%
  7. Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 2 people, 11.11%
  8. Neuralgia (pain in one or more nerves): 2 people, 11.11%
  9. Sleep Disorder: 2 people, 11.11%
  10. Musculoskeletal Chest Pain (pain in chest muscle or nerve or bones): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Kalbitor and Klor-con?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Kalbitor and Klor-con:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Kalbitor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Klor-con:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Kalbitor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Klor-con and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ecallantide and potassium chloride (the active ingredients of Kalbitor and Klor-con, respectively), and Kalbitor and Klor-con (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: